Home›Stock Screener›Phaarmasia›Financial Statements

Phaarmasia Complete Financial Statements

12 Years of Data
2026 - 2015

In FY2026, Phaarmasia (PHRMASI) reported revenue ₹47 Cr, net profit ₹18 Cr and EPS ₹25.74, with a net profit margin of 38.3% and ROE of 200.0%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Also explore PHRMASI share price charts to track price trends across different timeframes.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 38.30% 2026 data
EBITDA Margin 4.26% 2026 data
Operating Margin 4.00% 2026 data
Return on Assets 81.82% 2026 data
Return on Equity 200.00% 2026 data

Balance Sheet Ratios

Equity Ratio 40.91% 2026 data
Asset Turnover 2.14 2026 data

PHRMASI Revenue, Net Profit & EBITDA — Year-on-Year Growth

PHRMASI YoY (March 2025 vs March 2026) — revenue +88.0%, net profit +1000.0%, EBITDA +300.0%, expenses +73.1%. For live price, earnings ratios and company overview, see Phaarmasia share price today.

Revenue Growth
+88.0%
Year-over-Year
Net Profit Growth
+1000.0%
Year-over-Year
EBITDA Growth
+300.0%
Year-over-Year
Expense Growth
+73.1%
Year-over-Year
Assets Growth
-29.0%
Year-over-Year
Equity Growth
-10.0%
Year-over-Year

PHRMASI Income Statement — Revenue, EBITDA & Net Profit

Phaarmasia revenue ₹47 Cr, EBITDA ₹2 Cr, net profit ₹18 Cr, EPS ₹25.74 (2026) — net profit margin 38.3%. Analyse Phaarmasia ownership structure to track promoter, FII and institutional holdings.

Periods ₹ Crores
Particulars March 2026 March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Revenue 47 25 31 28 18 21 25 25 21 15 22 19
Expenses 45 26 31 29 19 20 24 24 20 14 21 18
EBITDA 2 -1 0 -1 -1 1 1 1 1 1 1 1
Operating Profit Margin % 4.00% -8.00% -3.00% -6.00% -10.00% 0.00% 3.00% 3.00% 3.00% 1.00% 1.00% 5.00%
Depreciation 0 0 0 0 0 0 0 1 1 0 1 1
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 21 -2 -1 -1 -2 1 1 1 1 0 0 0
Tax 4 0 0 0 0 0 0 0 0 0 0 0
Net Profit 18 -2 -1 -1 -2 0 1 1 1 0 0 0
Earnings Per Share (₹) 25.74 -2.33 -0.76 -1.84 -2.27 0.46 0.79 1.14 0.84 0.24 0.06 0.20

PHRMASI Balance Sheet — Assets, Liabilities & Shareholders' Equity

PHRMASI total assets ₹22 Cr, total equity ₹9 Cr, total liabilities ₹ Cr (2025) — ROE 200.0%.

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 22 31 28 21 22 34 33 22 20 19 19
Current Assets 8 18 15 8 9 20 19 8 6 4 4
Fixed Assets 12 13 13 13 13 13 14 14 14 14 16
Capital Work in Progress 0 0 0 0 0 0 0 0 0 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0
Other Assets 9 19 16 8 9 20 20 8 6 5 4
LIABILITIES
Total Liabilities
Current Liabilities 0 0 0 0 0 1 1 1 1 1 0
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 9 10 11 12 14 13 13 12 12 12 13
Share Capital 7 7 7 7 7 7 7 7 7 7 7
Reserves & Surplus 2 4 4 5 7 7 6 5 5 5 6

PHRMASI Cash Flow Statement — Operating, Investing & Financing

Phaarmasia operating cash flow ₹0 Cr, investing ₹0 Cr, financing ₹0 Cr, net cash flow ₹0 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities 0 0 1 0 0 0 0 1 0 0 1
Investing Activities 0 0 0 0 0 0 0 -1 0 0 0
Financing Activities 0 0 0 0 0 0 0 0 0 0 0
Net Cash Flow 0 0 1 0 0 0 0 0 0 0 0